Widespread occurrence of α-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies

Neuropathology and Applied Neurobiology

Volumn 25, Issue 5, 1999, Pages 363-368

  Wakabayashi, K ^a   Yoshimoto, M ^b   Fukushima, T ^c   Koide, R ^c   Horikawa, Y ^c   Morita, T ^c   Takahashi, H ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Medicinal Research Laboratories   (Japan)

^c Shinrakuen Hospital   (Japan)

Author keywords

synuclein; Hallervorden Spatz disease; Lewy body; NACP; Neuroaxonal dystrophy; Spheroid

Indexed keywords

ALPHA SYNUCLEIN; ANTIBODY;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CASE REPORT; CELL INCLUSION; CONTROLLED STUDY; GRAY MATTER; HALLERVORDEN SPATZ DISEASE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFERIOR OLIVE; LEWY BODY; LOCUS CERULEUS; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SYMPATHETIC GANGLION; THALAMUS;

ADULT; AGED; ALPHA-SYNUCLEIN; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; SYNUCLEINS; TISSUE DISTRIBUTION;

EID: 0032719237     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00193.x     Document Type: Article

References (40)

1. 1 Alberca R, Rafel E, Chinchon I, Vadillo J, Navarro A. Late onset Parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 1987; 50: 1665-8
2. 2 Antoine JC, Tommasi M, Chalumeau A, Jouvet-Telinge A, Bourrat C. Maladie de Hallervorden-Spatz avec Corps de Lewy. Rev Neurol (Paris) 1985; 12: 806-9
3. 3 Arawaka S, Saito Y, Murayama S, Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein. Neurology 1998; 51: 887-9
4. 4 Arima K, Uéda K, Sunohara N et al. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 1998; 808: 93-100
5. 5 Arima K, Uéda K, Sunohara N et al. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 1998; 96: 439-44
6. 6 Baba M, Nakajo S, Tu P-H, Tomita T, Nakaya K, Lee VM-Y, Trojanowski JQ, Iwatsubo T. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879-84
7. 7 Bornstein B, Sandbank U, Fried Y. Hallervorden Spatz disease associated with Lewy type inclusions. Confin Neurol 1966; 27: 397-405
8. 8 Chichibu M, Oyake Y, Murone I. An autopsy case of Hallervorden-Spatz syndrome with Lewy's inclusion body. Shinkei Kenkyu No Shimpo 1966; 10: 700-7
9. 9 Defendini R, Markesbery WR, Mastri AR, Duffy PE. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology. J Neurol Sci 1973; 20: 7-23
10. 10 Dickson DW, Ruan D, Crystal H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991; 41: 1402-9
11. 11 Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974; 30: 70-83
12. 12 Fuse S, Inoue K, Iwata M, Mannen T, Toyokura Y. An autopsy case of Hallervorden-Spatz disease with protracted course of about 30 years. Clin Neurol (Tokyo) 1987; 27: 155-67
13. 13 Gai WP, Power JHT, Blumbergs PC, Blessing WW. Multiple-system atrophy: a new α-synuclein disease? Lancet 1998; 352: 547-8
14. 14 Gaytan-Garcia S, Kaufmann JCE, Young GB. Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinicopathological study. Clin Neuropathol 1990; 9: 136-42
15. 15 Gibb WRG. Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 1986; 12: 223-34
16. 16 Gilman S, Barrett RE. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Clinical characteristics and nosological considerations. J Neurol Sci 1973; 19: 189-205
17. 17 Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Zentralbl Gesamte Neurol 1922; 79: 254-302
18. 18 Hayashi S, Akasaki Y, Morimura Y, Takauchi S, Sato M, Miyoshi K. An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles. Clin Neuropathol 1992; 11: 1-5
19. 19 Irizarry MC, Growdon W, Gomez-Isla T et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998; 57: 334-7
20. 20 Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Rohan de Silva HA, Kittel A, Saitoh T. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14: 467-75
21. 21 Jellinger K. Neuroaxonal dystrophy: its natural history and related disorders. In Progress in Neuropathology, Vol 2, Ed HM Zimmerman. New York: Grune & Stratton, Inc., 1973: 129-80
22. 22 Krüger R, Kuhn W, Müller T et al. Ala 30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet 1998; 18: 106-8
23. 23 Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nature Med 1998; 4: 755-7
24. 24 Park BE, Netsky MG, Betsill WL. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Peroxidation as a common mechanism. Neurology 1975; 25: 1172-8
25. 25 Polymeropoulos MH, Lavedan C, Leroy E et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-7
26. 26 Rozdilsky B, Bolton CF, Takeda M. Neuroaxonal dystrophy. A case of delayed onset and protracted course. Acta Neuropathol 1971; 17: 331-40
27. 27 Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997; 388: 839-40
28. 28 Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Purkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998; 95: 6469-73
29. 29 Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251: 205-8
30. 30 Sugiyama H, Hainfellner JA, Schmid-Siegel B, Budka H. Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol 1993; 12: 147-52
31. 31 Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998; 152: 367-72
32. 32 Taylor TD, Litt M, Kramer P et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nature Genet 1996; 14: 479-81
33. 33 Tu P-H, Galvin JE, Baba M et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998; 44: 415-22
34. 34 Vuia O. Neuroaxonal dystrophy, a juvenile-adult form. Clin Neurol Neurosury 1977; 79: 307-15
35. 35 Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997; 38 (Suppl. 2): 2-7
36. 36 Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 1997; 239: 45-8
37. 37 Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998; 249: 180-2
38. 38 Wakabayashi K, Hayashi S, Kakita A et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998; 96: 445-52
39. 39 Williamson K, Sima AAF, Curry B, Ludwin SK. Neuroaxonal dystrophy in young adults: a clinicopathological study of two unrelated cases. Ann Neurol 1982; 11: 335-43
40. 40 Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, Saitoh T. NACP, the precursor protein of the non-amyloid α/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Arad Sci USA 1995; 92: 9141-5